Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 970 of 1,261

  1. US 7906535

    High concentration topical insecticides containing pyrethroids

    Summit VetPharm, LLC · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  2. US 7906530

    1,7-naphthyridine derivatives as p38 MAP kinase inhibitors

    Laboratories Almirall, S.A. · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  3. US 7906550

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  4. US 7906628

    Targeting proteins to deliver therapeutic or diagnostic reagents

    The Board of Regents of the University of Texas System · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  5. US 7906644

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  6. US 7906962

    Dynamic nuclear polarization enhanced nuclear magnetic resonance of water under ambient conditions

    The Regents of the University of California · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  7. US 7906638

    Chimeric nucleic acids encoding polypeptides comprising CD70 and Fas ligand domains

    The Regents of the University of California · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  8. US 7906482

    Anti-obesity agents

    Advanced Diagnostics and Discovery · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  9. US 7906484

    Complex for transferring an anionic substance into a cell

    Alnylam Pharmaceuticals, Inc. · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  10. US 7906513

    Hydrazide-containing hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  11. US 7902168

    Compositions and methods for inhibiting expression of Nav1.8 gene

    Alnylam Pharmaceuticals, Inc. · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  12. US 7902221

    Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  13. US 7902167

    Compounds and methods for down-regulating Wrap53 protein by RNA interference

    APREA AB · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  14. US 7902228

    Schweinfurthin analogues

    The United States of America, National Institute of Health · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  15. US 7902241

    Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  16. US 7902441

    Chromosome 3p21.3 genes are tumor suppressors

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  17. US 7902348

    Janus family kinases and identification of immune modulators

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  18. US 7901453

    Coated implantable medical device

    Cook Regentec LLC · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  19. US 7902166

    Compositions comprising inhibitors of RNA binding proteins and methods of producing and using same

    The Board of Regents of the University of Oklahoma · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  20. US 7901921

    Viral purification methods

    ONCOLYTICS BIOTECH INC. · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  21. US 7902148

    Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent

    Theravance, Inc. · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  22. US 7902239

    Diaminotriazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  23. US 7902220

    8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  24. US 7902235

    Compounds for nonsense suppression, and methods for their use

    PTC THERAPEUTICS, INC. · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.